{"title":"Introducing the PLOS collection on rare cancer","link":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0308087","date":1722434400000,"content":"<p>by Mitesh J. Borad</p>\r\n\r\nRare cancers are defined by low incidence rates, and may lack evidence that supports uniform standards of care and relevant clinical guidelines. Rare cancers may represent up to 24% of all cancers, yet remain understudied and underappreciated in terms of their clinical and ultimately societal impact. The PLOS Rare Cancer Collection brings together a broad range of research endeavors that are being undertaken in rare cancers research ranging from basic biological evaluations to therapeutic drug development. This Overview presents a brief background to the Collection and highlights the contributions of included articles.","author":"Mitesh J. Borad","siteTitle":"PLOS ONE","siteHash":"e9ab556ceb1e4ea76e897a5fa4f394f0bb75c2c2f3d5b0f4766ff77b4a262ac1","entryHash":"9af81773a53c46474c405b73c9a3663d7f58fb93886da46318e7cd847e9356c3","category":"Interdisciplinary"}